PHC Holdings Corp is engaged in the development, manufacture and sale of healthcare devices and services.
2013
9.8K+
LTM Revenue $2.4B
LTM EBITDA $339M
$2.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
PHC Holdings has a last 12-month revenue of $2.4B and a last 12-month EBITDA of $339M.
In the most recent fiscal year, PHC Holdings achieved revenue of $2.4B and an EBITDA of $200M.
PHC Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See PHC Holdings valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $2.4B | $2.4B | XXX | XXX | XXX |
Gross Profit | $1.1B | $1.1B | XXX | XXX | XXX |
Gross Margin | 46% | 48% | XXX | XXX | XXX |
EBITDA | $328M | $200M | XXX | XXX | XXX |
EBITDA Margin | 14% | 9% | XXX | XXX | XXX |
Net Profit | -$56.2M | -$21.4M | XXX | XXX | XXX |
Net Margin | -2% | -1% | XXX | XXX | XXX |
Net Debt | $1.4B | $1.5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 24, 2025, PHC Holdings's stock price is JPY 959 (or $6).
PHC Holdings has current market cap of JPY 121B (or $804M), and EV of JPY 344B (or $2.3B).
See PHC Holdings trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.3B | $804M | XXX | XXX | XXX | XXX | $0.58 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 24, 2025, PHC Holdings has market cap of $804M and EV of $2.3B.
PHC Holdings's trades at 0.9x LTM EV/Revenue multiple, and 6.7x LTM EBITDA.
Analysts estimate PHC Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for PHC Holdings and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $2.3B | XXX | XXX | XXX |
EV/Revenue | 1.0x | XXX | XXX | XXX |
EV/EBITDA | 7.5x | XXX | XXX | XXX |
P/E | 24.0x | XXX | XXX | XXX |
P/E/Growth | 0.4x | XXX | XXX | XXX |
EV/FCF | 14.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPHC Holdings's NTM/LTM revenue growth is 1%
PHC Holdings's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, PHC Holdings's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate PHC Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for PHC Holdings and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -1% | XXX | XXX | XXX | XXX |
EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
EBITDA Growth | -39% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 14% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 42% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 44% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PHC Holdings acquired XXX companies to date.
Last acquisition by PHC Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . PHC Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was PHC Holdings founded? | PHC Holdings was founded in 2013. |
Where is PHC Holdings headquartered? | PHC Holdings is headquartered in Japan. |
How many employees does PHC Holdings have? | As of today, PHC Holdings has 9.8K+ employees. |
Who is the CEO of PHC Holdings? | PHC Holdings's CEO is Ms. Kyoko Deguchi. |
Is PHC Holdings publicy listed? | Yes, PHC Holdings is a public company listed on TKS. |
What is the stock symbol of PHC Holdings? | PHC Holdings trades under 6523 ticker. |
When did PHC Holdings go public? | PHC Holdings went public in 2021. |
Who are competitors of PHC Holdings? | Similar companies to PHC Holdings include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of PHC Holdings? | PHC Holdings's current market cap is $804M |
What is the current revenue of PHC Holdings? | PHC Holdings's last 12-month revenue is $2.4B. |
What is the current EBITDA of PHC Holdings? | PHC Holdings's last 12-month EBITDA is $339M. |
What is the current EV/Revenue multiple of PHC Holdings? | Current revenue multiple of PHC Holdings is 0.9x. |
What is the current EV/EBITDA multiple of PHC Holdings? | Current EBITDA multiple of PHC Holdings is 6.7x. |
What is the current revenue growth of PHC Holdings? | PHC Holdings revenue growth between 2023 and 2024 was -1%. |
Is PHC Holdings profitable? | Yes, PHC Holdings is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.